To verify whether this pathway is also triggered by CV compounds in depigmented melanoma cells, we examined the potential involvement in this process of three kinases, including receptor interacting protein kinase 1 (RIPK1), RIPK3, and mixed lineage kinase domain-like protein (MLKL), which are the main executioners of necroptotic cell death. The gene discussed is MLKL; the disease is melanoma.